UNC Health Care

Category: Vaccines

July 10, 2017

Pregnant women should be included in Zika virus vaccine research, n...

The inclusion of pregnant women in Zika virus vaccine research is crucial to solving the international health crisis, according to new guidance published by UNC’s Center for Bioethics and two other universities.

Babies, Children, Contagions, Fertility, Pregnancy, Research, Vaccines, Zika

Read Article
UNC Chapel

March 13, 2017

‘Conversations with Innovators:’ UNC hematologist on promising drug...

Kenneth Ataga, MD, director of the UNC Comprehensive Sickle Cell Program, was featured in a video by the American Society of Hematology in which he discussed the favorable results of a yearlong clinical trial studying crizanlizumab as a therapy to prevent and treat painful crisis events in patients with sickle cell disease.

Clinical Trials, Hematology, Vaccines

Read Article

February 26, 2014

UNC researchers discover new target for dengue virus vaccine

By re-engineering a tiny chain of amino acids in one type of dengue virus, Ralph Baric and Aravinda de Silva discover a new path toward solving the dengue vaccine dilemma. The research has the potential to transform vaccine development for other diseases, including SARS and HIV.

Research, Vaccines

Read Article

February 14, 2014

Corbett continues quest for dengue fever vaccine

In this new series, we profile graduate students who conduct research in labs across the UNC School of Medicine. First up is Kizzmekia Corbett, who received an off-campus dissertation fellowship from the UNC Graduate School to travel to Sri Lanka. Corbett will collect blood samples to search for a specific antibody response to the dengue virus, a key step in creating a vaccine for the world's most widespread mosquito-borne disease.

Physician Stories, Research, Vaccines

Read Article
Dr. Peter Leone of UNC is a co-author of the study.

January 4, 2012

Research shows progress toward a genital herpes vaccine

More than 8,000 women participated in the NIH-funded study, which was conducted in part at UNC. The vaccine was partially effective at preventing herpes simplex virus type 1 (HSV-1), but did not protect women from herpes simplex virus type 2 (HSV-2).

Research, Sexual Health, Vaccines

Read Article